Publicaciones en colaboración con investigadores/as de Universitat de València (20)

2023

  1. Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Translation of a tissue epigenetic signature to circulating free DNA suggests BCAT1 as a potential noninvasive diagnostic biomarker for lung cancer

    Clinical Epigenetics, Vol. 14, Núm. 1

2021

  1. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  2. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  3. Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 6, pp. 586-598

2020

  1. Comprehensive analysis of SWI/SNF inactivation in lung adenocarcinoma cell models

    Cancers, Vol. 12, Núm. 12, pp. 1-14

  2. Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors

    Annals of Oncology, Vol. 31, Núm. 2, pp. 274-282

2019

  1. Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

    Scientific Reports, Vol. 9, Núm. 1

  2. Tmprss4: A novel tumor prognostic indicator for the stratification of stage ia tumors and a liquid biopsy biomarker for nsclc patients

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2018

  1. Blockade of the complement C5a/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 9, pp. 1164-1176

2017

  1. Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213

  2. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy

    Cell and Tissue Research, Vol. 370, Núm. 1, pp. 29-39

  3. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche

    Cancer Letters, Vol. 402, pp. 43-51

2015

  1. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

    Oral Diseases, Vol. 21, Núm. 7, pp. 899-904

  2. Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake

    Circulation, Vol. 131, Núm. 9, pp. 815-826

  3. Synaptic connectivity of the cholinergic axons in the olfactory bulb of the cynomolgus monkey

    Frontiers in Neuroanatomy, Vol. 9, Núm. MAR

2013

  1. Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer

    Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393

  2. Two types of periglomerular cells in the olfactory bulb of the macaque monkey (Macaca fascicularis)

    Brain Structure and Function, Vol. 218, Núm. 4, pp. 873-887

2010

  1. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat

    Cell Transplantation, Vol. 19, Núm. 3, pp. 313-328